✦ LIBER ✦

A Phase III, randomized study to evaluate the immunogenicity and safety of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in HIV-positive adults

✍ Scribed by Diaz, Ricardo Sobhie; Tenore, Simone Barros; da Silva, Mônica M. Gomes; da Cunha, Clovis Arns

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of an MF59®-ad

✍ Timo Vesikari; Aino Forstén; Karl-Heinz Herbinger; Giovanni Della Cioppa; Jenny 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Safety and immunogenicity of a monovalen

✍ Paolo Palma; Maria Luisa Romiti; Stefania Bernardi; Giuseppe Pontrelli; Nadia Mo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Immunogenicity, safety and tolerability

✍ Susanna Esposito; Emanuela D’Angelo; Cristina Daleno; Francesco Peia; Alessia Sc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Assessment of the immunogenicity and saf

✍ Hiroyuki Fukase; Hidetoshi Furuie; Yuji Yasuda; Ryoya Komatsu; Kenji Matsushita; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Safety and reactogenicity profile of an

✍ Hans C. Rümke; José-María Bayas; José-Ramón de Juanes; Covadonga Caso; Jan Hendr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Long-lasting immunogenicity and safety o

✍ G. V. Zuccotti; E. Pariani; A. Scaramuzza; L. Santoro; E. Giani; M. Macedoni; A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB